A citation-based method for searching scientific literature

G M Pitari, P Li, J E Lin, D Zuzga, A V Gibbons, A E Snook, S Schulz, S A Waldman. Clin Pharmacol Ther 2007
Times Cited: 45







List of co-cited articles
408 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Guanylyl cyclase C suppresses intestinal tumorigenesis by restricting proliferation and maintaining genomic integrity.
Peng Li, Stephanie Schulz, Alessandro Bombonati, Juan P Palazzo, Terry M Hyslop, Yihuan Xu, Amy A Baran, Linda D Siracusa, Giovanni M Pitari, Scott A Waldman. Gastroenterology 2007
101
71

Guanylyl cyclase C is a selective marker for metastatic colorectal tumors in human extraintestinal tissues.
S L Carrithers, M T Barber, S Biswas, S J Parkinson, P K Park, S D Goldstein, S A Waldman. Proc Natl Acad Sci U S A 1996
178
60

Uroguanylin treatment suppresses polyp formation in the Apc(Min/+) mouse and induces apoptosis in human colon adenocarcinoma cells via cyclic GMP.
K Shailubhai, H H Yu, K Karunanandaa, J Y Wang, S L Eber, Y Wang, N S Joo, H D Kim, B W Miedema, S Z Abbas,[...]. Cancer Res 2000
170
57

Homeostatic control of the crypt-villus axis by the bacterial enterotoxin receptor guanylyl cyclase C restricts the proliferating compartment in intestine.
Peng Li, Jieru E Lin, Inna Chervoneva, Stephanie Schulz, Scott A Waldman, Giovanni M Pitari. Am J Pathol 2007
86
55

A validated quantitative assay to detect occult micrometastases by reverse transcriptase-polymerase chain reaction of guanylyl cyclase C in patients with colorectal cancer.
Stephanie Schulz, Terry Hyslop, Janis Haaf, Christine Bonaccorso, Karl Nielsen, Matthew E Witek, Ruth Birbe, Juan Palazzo, David Weinberg, Scott A Waldman. Clin Cancer Res 2006
64
53

Guanylyl cyclase C is a marker of intestinal metaplasia, dysplasia, and adenocarcinoma of the gastrointestinal tract.
Ruth Birbe, Juan P Palazzo, Rhonda Walters, David Weinberg, Stephanie Schulz, Scott A Waldman. Hum Pathol 2005
91
51

Guanylyl cyclases and signaling by cyclic GMP.
K A Lucas, G M Pitari, S Kazerounian, I Ruiz-Stewart, J Park, S Schulz, K P Chepenik, S A Waldman. Pharmacol Rev 2000
907
46

Guanylyl cyclase C agonists regulate progression through the cell cycle of human colon carcinoma cells.
G M Pitari, M D Di Guglielmo, J Park, S Schulz, S A Waldman. Proc Natl Acad Sci U S A 2001
126
46


Guanylyl cyclase C messenger RNA is a biomarker for recurrent stage II colorectal cancer.
B Cagir, A Gelmann, J Park, T Fava, A Tankelevitch, E W Bittner, E J Weaver, J P Palazzo, D Weinberg, R D Fry,[...]. Ann Intern Med 1999
97
42

Bacterial enterotoxins are associated with resistance to colon cancer.
G M Pitari, L V Zingman, D M Hodgson, A E Alekseev, S Kazerounian, M Bienengraeber, G Hajnóczky, A Terzic, S A Waldman. Proc Natl Acad Sci U S A 2003
116
42

Expression of guanylin is downregulated in mouse and human intestinal adenomas.
K A Steinbrecher, T M Tuohy, K Heppner Goss, M C Scott, D P Witte, J Groden, M B Cohen. Biochem Biophys Res Commun 2000
66
40

Guanylin mRNA expression in human intestine and colorectal adenocarcinoma.
M B Cohen, J A Hawkins, D P Witte. Lab Invest 1998
73
37

Association of GUCY2C expression in lymph nodes with time to recurrence and disease-free survival in pN0 colorectal cancer.
Scott A Waldman, Terry Hyslop, Stephanie Schulz, Alan Barkun, Karl Nielsen, Janis Haaf, Christine Bonaccorso, Yanyan Li, David S Weinberg. JAMA 2009
83
37

The hormone receptor GUCY2C suppresses intestinal tumor formation by inhibiting AKT signaling.
Jieru Egeria Lin, Peng Li, Adam Eugene Snook, Stephanie Schulz, Abhijit Dasgupta, Terry Marie Hyslop, Ahmara Vivian Gibbons, Glen Marszlowicz, Giovanni Mario Pitari, Scott Arthur Waldman. Gastroenterology 2010
80
37

Guanylyl cyclase C: a molecular marker for staging and postoperative surveillance of patients with colorectal cancer.
Glen S Frick, Giovanni M Pitari, David S Weinberg, Terry Hyslop, Stephanie Schulz, Scott A Waldman. Expert Rev Mol Diagn 2005
50
35

Targeted inactivation of the mouse guanylin gene results in altered dynamics of colonic epithelial proliferation.
Kris A Steinbrecher, Steve A Wowk, Jeffrey A Rudolph, David P Witte, Mitchell B Cohen. Am J Pathol 2002
84
35

Systemic therapy for colorectal cancer.
Jeffrey A Meyerhardt, Robert J Mayer. N Engl J Med 2005
831
33

Guanylyl cyclase is a heat-stable enterotoxin receptor.
S Schulz, C K Green, P S Yuen, D L Garbers. Cell 1990
527
33

The putative tumor suppressor Cdx2 is overexpressed by human colorectal adenocarcinomas.
Matthew E Witek, Karl Nielsen, Rhonda Walters, Terry Hyslop, Juan Palazzo, Stephanie Schulz, Scott A Waldman. Clin Cancer Res 2005
70
31

The staging of colorectal cancer: 2004 and beyond.
Carolyn C Compton, Frederick L Greene. CA Cancer J Clin 2004
298
31


Gene expression in colorectal cancer.
Karin Birkenkamp-Demtroder, Lise Lotte Christensen, Sanne Harder Olesen, Casper M Frederiksen, Päivi Laiho, Lauri A Aaltonen, Søren Laurberg, Flemming B Sørensen, Rikke Hagemann, Torben F ØRntoft. Cancer Res 2002
200
28

Interruption of homologous desensitization in cyclic guanosine 3',5'-monophosphate signaling restores colon cancer cytostasis by bacterial enterotoxins.
Giovanni M Pitari, Ronnie I Baksh, David M Harris, Peng Li, Shiva Kazerounian, Scott A Waldman. Cancer Res 2005
32
40

Use of guanylyl cyclase C for detecting micrometastases in lymph nodes of patients with colon cancer.
S A Waldman, B Cagir, J Rakinic, R D Fry, S D Goldstein, G Isenberg, M Barber, S Biswas, C Minimo, J Palazzo,[...]. Dis Colon Rectum 1998
79
26

Is occult lymph node disease in colorectal cancer patients clinically significant? A review of the relevant literature.
Daniel G Nicastri, John T Doucette, Tony E Godfrey, Steven J Hughes. J Mol Diagn 2007
86
26

Escherichia coli heat-stable toxin receptors in human colonic tumors.
S L Carrithers, S J Parkinson, S Goldstein, P Park, D C Robertson, S A Waldman. Gastroenterology 1994
80
26

Prognostic impact of micrometastases in colon cancer: interim results of a prospective multicenter trial.
Anton J Bilchik, Dave S B Hoon, Sukamal Saha, Roderick R Turner, David Wiese, Maggie DiNome, Kazuo Koyanagi, Martin McCarter, Perry Shen, Douglas Iddings,[...]. Ann Surg 2007
113
24

Adjuvant chemotherapy versus observation in patients with colorectal cancer: a randomised study.
Richard Gray, Jennifer Barnwell, Christopher McConkey, Robert K Hills, Norman S Williams, David J Kerr. Lancet 2007
837
24

Accurate lymph-node detection in colorectal specimens resected for cancer is of prognostic significance.
C Ratto, L Sofo, M Ippoliti, M Merico, M Bossola, F M Vecchio, G B Doglietto, F Crucitti. Dis Colon Rectum 1999
144
22

Colorectal cancer is a paracrine deficiency syndrome amenable to oral hormone replacement therapy.
P Li, J E Lin, A E Snook, A V Gibbons, D S Zuzga, S Schulz, G M Pitari, S A Waldman. Clin Transl Sci 2008
17
58

Gene expression profiles in normal and cancer cells.
L Zhang, W Zhou, V E Velculescu, S E Kern, R H Hruban, S R Hamilton, B Vogelstein, K W Kinzler. Science 1997
22

Guanylin and uroguanylin induce natriuresis in mice lacking guanylyl cyclase-C receptor.
Stephen L Carrithers, Cobern E Ott, Michael J Hill, Brett R Johnson, Weiyan Cai, Jason J Chang, Rajesh G Shah, Congmei Sun, Elizabeth A Mann, Manasses C Fonteles,[...]. Kidney Int 2004
71
22

Cancer statistics, 2007.
Ahmedin Jemal, Rebecca Siegel, Elizabeth Ward, Taylor Murray, Jiaquan Xu, Michael J Thun. CA Cancer J Clin 2007
20

Micrometastases and survival in stage II colorectal cancer.
G J Liefers, A M Cleton-Jansen, C J van de Velde, J Hermans, J H van Krieken, C J Cornelisse, R A Tollenaar. N Engl J Med 1998
524
20

American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancer.
Al B Benson, Deborah Schrag, Mark R Somerfield, Alfred M Cohen, Alvaro T Figueredo, Patrick J Flynn, Monika K Krzyzanowska, Jean Maroun, Pamela McAllister, Eric Van Cutsem,[...]. J Clin Oncol 2004
964
20

Relative quantification based on logistic models for individual polymerase chain reactions.
Inna Chervoneva, Yanyan Li, Boris Iglewicz, Scott Waldman, Terry Hyslop. Stat Med 2007
21
38

Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer.
Thierry André, Corrado Boni, Lamia Mounedji-Boudiaf, Matilde Navarro, Josep Tabernero, Tamas Hickish, Clare Topham, Marta Zaninelli, Philip Clingan, John Bridgewater,[...]. N Engl J Med 2004
17

Guanylyl cyclase C in colorectal cancer: susceptibility gene and potential therapeutic target.
Jieru E Lin, Peng Li, Giovanni M Pitari, Stephanie Schulz, Scott A Waldman. Future Oncol 2009
19
42




Loss of guanylyl cyclase C (GCC) signaling leads to dysfunctional intestinal barrier.
Xiaonan Han, Elizabeth Mann, Shila Gilbert, Yanfang Guan, Kris A Steinbrecher, Marshall H Montrose, Mitchell B Cohen. PLoS One 2011
61
17

GUCY2C opposes systemic genotoxic tumorigenesis by regulating AKT-dependent intestinal barrier integrity.
Jieru Egeria Lin, Adam Eugene Snook, Peng Li, Brian Arthur Stoecker, Gilbert Won Kim, Michael Sullivan Magee, Alex Vladimir Mejia Garcia, Michael Anthony Valentino, Terry Hyslop, Stephanie Schulz,[...]. PLoS One 2012
59
17

Microarray versus conventional prediction of lymph node metastasis in colorectal carcinoma.
Roland S Croner, Andrea Peters, Wolfgang M Brueckl, Klaus E Matzel, Ludger Klein-Hitpass, Thomas Brabletz, Thomas Papadopoulos, Werner Hohenberger, Bertram Reingruber, Berthold Lausen. Cancer 2005
35
20

Adjuvant treatment of colorectal cancer.
Brian M Wolpin, Jeffrey A Meyerhardt, Harvey J Mamon, Robert J Mayer. CA Cancer J Clin 2007
191
15

A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer.
Soonmyung Paik, Steven Shak, Gong Tang, Chungyeul Kim, Joffre Baker, Maureen Cronin, Frederick L Baehner, Michael G Walker, Drew Watson, Taesung Park,[...]. N Engl J Med 2004
15

Allelic loss of chromosome 18q and prognosis in colorectal cancer.
J Jen, H Kim, S Piantadosi, Z F Liu, R C Levitt, P Sistonen, K W Kinzler, B Vogelstein, S R Hamilton. N Engl J Med 1994
626
15

New directions in the treatment of colorectal cancer: a look to the future.
A Sobrero, D Kerr, B Glimelius, E Van Cutsem, G Milano, D M Pritchard, P Rougier, M Aapro. Eur J Cancer 2000
75
15

Uroguanylin: structure and activity of a second endogenous peptide that stimulates intestinal guanylate cyclase.
F K Hamra, L R Forte, S L Eber, N V Pidhorodeckyj, W J Krause, R H Freeman, D T Chin, J A Tompkins, K F Fok, C E Smith. Proc Natl Acad Sci U S A 1993
296
15


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.